Pulmonary Hypertension in Parenchymal Lung Disease
نویسندگان
چکیده
Idiopathic pulmonary arterial hypertension (IPAH) has been extensively investigated, although it represents a less common form of the pulmonary hypertension (PH) family, as shown by international registries. Interestingly, in types of PH that are encountered in parenchymal lung diseases such as interstitial lung diseases (ILDs), chronic obstructive pulmonary disease (COPD), and many other diffuse parenchymal lung diseases, some of which are very common, the available data is limited. In this paper, we try to browse in the latest available data regarding the occurrence, pathogenesis, and treatment of PH in chronic parenchymal lung diseases.
منابع مشابه
THE DIAGNOSTIC YIELD OF TRANSBRONCHIAL LUNG BIOPSY IN DIFFUSE INFILTRATIVE PULMONARY DISEASES BY PLAIN CUP FORCEPS. A STUDY OF 54 CASES IN IRAN
The technique of transbronchial lung biopsy (TBLB) has expanded the diagnostic yield of bronchoscopy . In this article we are presenting 54 patients with diffuse pulmonary parenchymal involvement who underwent this procedure during six years between June 1980 and December 1989. The diagnostic yield of this technique in diffuse pulmonary parenchymal disease is great and was 66 percent exclu...
متن کاملStatins and Pulmonary Hypertension in Chronic Obstructive Lung Disease
Chronic obstructive lung disease (COPD) is a chronic multisystem disease with a considerable burden. One of its most common complications is pulmonary artery hypertension (PAH). It has been demonstrated that the development of PAH is correlated with decreased quality of life and survival. Different medications have been proposed for the treatment of PAH, among which one can name statins. Howeve...
متن کاملOral Sildenafil has No Acute Effect on Diffusion Capacity Measurements in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension
Diffuse parenchymal lung diseases have diverse etiology and treatment often requires individualization taking into consideration comorbidities. Pulmonary hypertension represents one such comorbidity which, when present, worsens prognosis and confounds approach to treatment. Sildenafil is a pulmonary vasodilator, which has recently generated considerable interest for use in patients with diffuse...
متن کاملEUROPEAN RESPIRATORY UPDATE Update on diffuse parenchymal lung disease
I n recent years, there have been important advances in the understanding of diffuse parenchymal lung diseases, especially in relation to the idiopathic interstitial pneumonias, including idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Among other diffuse parenchymal lung diseases, the topics of particular interest centred on hypersensitivity pneumonia, parenchymal disease...
متن کاملدرگیری پارانشیم ریه در بیماران سیستمیک اسکلروزیس در بیمارستان نور و الزهرای اصفهان
Background & Aim:Systemic sclerosis is a multisystem autoimmune disorder with multiple organ involvements characterized by inflammation and fibrosis involving the skin as well as internal organs. Pulmonary involvement consists of interstitial fibrosis and pulmonary vascular disease has an important effect on the course and survival of these patients. In this study, we investigated the prev...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
دوره 2012 شماره
صفحات -
تاریخ انتشار 2012